source
- Artelo’s oral cannabinoid agonist matches semaglutide weight loss in obese mice, doubles effect when combinedArtelo Biosciences reported that its oral dual cannabinoid agonist, ART27.13, produced weight loss in diet‑induced obese mice that was comparable to the GLP‑1 receptor agonist semaglutide. In a fo…
- FDA updates instructions for NOxBOXi nitric oxide delivery system after leak risk identifiedThe FDA has issued a correction for the NOxBOXi nitric oxide delivery system with the NOxMixer module after discovering that the device can leak oxygen during inhaled nitric oxide therapy. The age…